Skip to main content
Premium Trial:

Request an Annual Quote

Patrick Finn

Twist Bioscience named Patrick Finn vice president of sales and marketing. He joins the company as it prepares to launch its synthetic biology platform services this year. Finn was previously at Enzymatics, where he was VP of sales and marketing. Prior to that, he was director of business development at Agilent Technologies, director of product development at Beckman Coulter Molecular Diagnostics, and held various positions at Invitrogen and GE Healthcare/Amersham International.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.